Posted on 2/15/19

TherapeuticsMD: The Future Still Looks Bright

SummaryImvexxy and Bijuva are differentiated and compelling products that address an existing market need.Impact of emerging competition for Bijuva likely overblown.Annovera is essentially a superior Nuvaring . . .